Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 3747 | 50.56 |
09:34 ET | 2100 | 50.36 |
09:36 ET | 2134 | 50.59 |
09:38 ET | 10438 | 51.078 |
09:39 ET | 350 | 50.975 |
09:41 ET | 28266 | 51.34 |
09:43 ET | 1300 | 51.1 |
09:45 ET | 4760 | 51.305 |
09:48 ET | 1400 | 51.24 |
09:50 ET | 17169 | 51.22 |
09:52 ET | 6113 | 51.23 |
09:54 ET | 2218 | 51.275 |
09:56 ET | 2800 | 51.25 |
09:57 ET | 8491 | 51.43 |
09:59 ET | 1387 | 51.38 |
10:01 ET | 2425 | 51.59 |
10:03 ET | 2066 | 51.48 |
10:06 ET | 500 | 51.43 |
10:08 ET | 4500 | 51.405 |
10:10 ET | 800 | 51.325 |
10:12 ET | 700 | 51.28 |
10:14 ET | 3371 | 51.26 |
10:15 ET | 3595 | 51.21 |
10:17 ET | 2800 | 51.1 |
10:19 ET | 1200 | 51.05 |
10:21 ET | 1137 | 51.085 |
10:24 ET | 4011 | 51.11 |
10:26 ET | 11979 | 50.848 |
10:28 ET | 200 | 50.81 |
10:30 ET | 2800 | 50.88 |
10:32 ET | 650 | 51.01 |
10:33 ET | 1703 | 51.09 |
10:35 ET | 1200 | 51.16 |
10:37 ET | 4139 | 51.27 |
10:39 ET | 3500 | 51.45 |
10:42 ET | 1103 | 51.27 |
10:44 ET | 500 | 51.25 |
10:46 ET | 857 | 51.25 |
10:48 ET | 300 | 51.29 |
10:50 ET | 2165 | 51.255 |
10:51 ET | 181 | 51.24 |
10:53 ET | 600 | 51.25 |
10:55 ET | 1880 | 51.27 |
10:57 ET | 3565 | 51.19 |
11:00 ET | 800 | 51.125 |
11:02 ET | 1117 | 51.12 |
11:04 ET | 200 | 51.07 |
11:06 ET | 1631 | 51.205 |
11:08 ET | 100 | 51.2 |
11:09 ET | 150 | 51.24 |
11:11 ET | 100 | 51.295 |
11:13 ET | 1000 | 51.29 |
11:15 ET | 800 | 51.265 |
11:18 ET | 2320 | 51.2503 |
11:20 ET | 1895 | 51.2 |
11:22 ET | 300 | 51.12 |
11:24 ET | 3459 | 51.2 |
11:26 ET | 400 | 51.19 |
11:29 ET | 2705 | 51.212 |
11:31 ET | 1881 | 51.242 |
11:33 ET | 100 | 51.17 |
11:36 ET | 1649 | 51.15 |
11:38 ET | 400 | 51.15 |
11:40 ET | 500 | 51.145 |
11:42 ET | 25200 | 51.18 |
11:44 ET | 3012 | 51.08 |
11:45 ET | 3400 | 51.215 |
11:47 ET | 2116 | 51.21 |
11:49 ET | 5500 | 51.14 |
11:51 ET | 4059 | 51.06 |
11:54 ET | 1050 | 51.09 |
11:56 ET | 1400 | 51.05 |
11:58 ET | 2567 | 51.02 |
12:00 ET | 2038 | 51.03 |
12:02 ET | 2228 | 51.035 |
12:03 ET | 400 | 51.07 |
12:05 ET | 3201 | 51.05 |
12:09 ET | 427 | 51.08 |
12:12 ET | 5997 | 51.14 |
12:14 ET | 600 | 51.17 |
12:16 ET | 9097 | 51.11 |
12:18 ET | 1632 | 51.05 |
12:20 ET | 2134 | 51.15 |
12:21 ET | 375 | 51.14 |
12:23 ET | 900 | 51.06 |
12:25 ET | 248 | 51 |
12:32 ET | 444 | 50.99 |
12:34 ET | 1421 | 51.07 |
12:36 ET | 200 | 51.05 |
12:38 ET | 1150 | 51.1 |
12:39 ET | 200 | 51.085 |
12:41 ET | 1613 | 51.025 |
12:43 ET | 500 | 51.025 |
12:48 ET | 200 | 51.07 |
12:50 ET | 1566 | 51.04 |
12:52 ET | 3825 | 51.005 |
12:54 ET | 6059 | 50.875 |
12:56 ET | 200 | 50.805 |
12:57 ET | 2623 | 51 |
01:01 ET | 300 | 50.91 |
01:03 ET | 100 | 50.8279 |
01:06 ET | 591 | 51 |
01:08 ET | 300 | 50.91 |
01:10 ET | 800 | 50.96 |
01:12 ET | 8685 | 51 |
01:14 ET | 400 | 50.96 |
01:15 ET | 100 | 50.96 |
01:17 ET | 600 | 50.78 |
01:19 ET | 2200 | 50.755 |
01:21 ET | 1976 | 50.68 |
01:24 ET | 2400 | 50.66 |
01:26 ET | 2297 | 50.5501 |
01:28 ET | 1200 | 50.625 |
01:30 ET | 1256 | 50.75 |
01:33 ET | 100 | 50.71 |
01:35 ET | 100 | 50.69 |
01:37 ET | 4969 | 50.78 |
01:39 ET | 100 | 50.78 |
01:42 ET | 100 | 50.775 |
01:44 ET | 200 | 50.775 |
01:46 ET | 2700 | 50.84 |
01:48 ET | 100 | 50.89 |
01:51 ET | 700 | 50.9 |
01:53 ET | 600 | 50.84 |
02:00 ET | 700 | 50.8 |
02:02 ET | 951 | 50.815 |
02:04 ET | 400 | 50.82 |
02:08 ET | 2000 | 50.86 |
02:09 ET | 944 | 50.78 |
02:11 ET | 100 | 50.79 |
02:13 ET | 300 | 50.865 |
02:15 ET | 308 | 50.84 |
02:18 ET | 200 | 50.89 |
02:20 ET | 1200 | 50.83 |
02:24 ET | 100 | 50.81 |
02:26 ET | 1004 | 50.81 |
02:27 ET | 1700 | 50.89 |
02:31 ET | 1211 | 50.885 |
02:33 ET | 800 | 50.89 |
02:36 ET | 112 | 50.885 |
02:38 ET | 100 | 50.91 |
02:40 ET | 1705 | 50.92 |
02:42 ET | 319 | 50.915 |
02:44 ET | 1390 | 50.915 |
02:45 ET | 1766 | 50.95 |
02:47 ET | 100 | 50.955 |
02:49 ET | 1151 | 50.96 |
02:51 ET | 4210 | 50.94 |
02:54 ET | 1836 | 50.85 |
02:56 ET | 951 | 50.98 |
02:58 ET | 100 | 50.98 |
03:00 ET | 100 | 50.93 |
03:02 ET | 300 | 50.91 |
03:03 ET | 894 | 50.93 |
03:05 ET | 1570 | 50.925 |
03:09 ET | 1426 | 50.975 |
03:12 ET | 1267 | 51.03 |
03:14 ET | 2401 | 51 |
03:16 ET | 1543 | 51 |
03:18 ET | 1700 | 50.915 |
03:20 ET | 700 | 50.86 |
03:21 ET | 200 | 50.845 |
03:23 ET | 200 | 50.88 |
03:25 ET | 512 | 50.735 |
03:27 ET | 1501 | 50.79 |
03:30 ET | 113 | 50.76 |
03:32 ET | 370 | 50.74 |
03:34 ET | 2074 | 50.75 |
03:36 ET | 200 | 50.78 |
03:38 ET | 200 | 50.73 |
03:39 ET | 1100 | 50.81 |
03:41 ET | 1775 | 50.77 |
03:43 ET | 1100 | 50.74 |
03:45 ET | 2500 | 50.78 |
03:48 ET | 1300 | 50.75 |
03:50 ET | 1866 | 50.695 |
03:52 ET | 3444 | 50.685 |
03:54 ET | 4274 | 50.755 |
03:56 ET | 12591 | 50.82 |
03:57 ET | 8130 | 50.74 |
03:59 ET | 82216 | 50.58 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.0B | -13.4x | --- |
Immunovant Inc | 4.1B | -14.8x | --- |
BridgeBio Pharma Inc | 4.6B | -9.3x | --- |
Dyne Therapeutics Inc | 3.5B | -9.7x | --- |
Madrigal Pharmaceuticals Inc | 4.6B | -8.4x | --- |
Apogee Therapeutics Inc | 3.4B | -25.8x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0B |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.64 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -13.4x |
Price/Sales (TTM) | 2,922.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.